COVID-19 Acute Respiratory Distress Syndrome: Treatment with Helmet CPAP in Respiratory Intermediate Care Unit by Pulmonologists in the Three Italian Pandemic Waves.


Journal

Advances in respiratory medicine
ISSN: 2543-6031
Titre abrégé: Adv Respir Med
Pays: Switzerland
ID NLM: 101697329

Informations de publication

Date de publication:
20 Sep 2023
Historique:
received: 08 08 2023
revised: 14 09 2023
accepted: 15 09 2023
medline: 25 9 2023
pubmed: 22 9 2023
entrez: 22 9 2023
Statut: epublish

Résumé

COVID-19 Acute Respiratory Distress Syndrome (CARDS) is the most serious complication of COVID-19. The SARS-CoV-2 outbreaks rapidly saturated intensive care unit (ICU), forcing the application of non-invasive respiratory support (NIRS) in respiratory intermediate care unit (RICU). The primary aim of this study is to compare the patients' clinical characteristics and outcomes (Helmet-Continuous Positive Airway Pressure (H-CPAP) success/failure and survival/death). The secondary aim is to evaluate and detect the main predictors of H-CPAP success and survival/death. A total of 515 patients were enrolled in our observational prospective study based on CARDS developed in RICU during the three Italian pandemic waves. All selected patients were treated with H-CPAP. The worst ratio of arterial partial pressure of oxygen (PaO

Identifiants

pubmed: 37736976
pii: arm91050030
doi: 10.3390/arm91050030
pmc: PMC10514851
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

383-396

Références

Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300
pubmed: 32228035
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Am J Respir Crit Care Med. 2003 Dec 15;168(12):1438-44
pubmed: 14500259
JAMA. 2016 Jun 14;315(22):2435-41
pubmed: 27179847
Chin Med J (Engl). 2020 May 5;133(9):1015-1024
pubmed: 32004165
Respir Res. 2020 Jul 28;21(1):198
pubmed: 32723327
J Cardiothorac Vasc Anesth. 2020 Oct;34(10):2575-2579
pubmed: 32540245
Crit Care. 2017 Sep 12;21(1):240
pubmed: 28899408
J Intensive Care. 2020 Jul 10;8:49
pubmed: 32665858
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Pol Arch Intern Med. 2017 Sep 29;127(9):614-620
pubmed: 28820175
J Clin Med. 2020 Apr 22;9(4):
pubmed: 32331217
PLoS One. 2022 Jan 14;17(1):e0262315
pubmed: 35030205
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1319-1320
pubmed: 32281885
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Intensive Care Med. 2014 Jul;40(7):942-9
pubmed: 24817030
Br J Anaesth. 2022 Feb;128(2):352-362
pubmed: 34774295
AJR Am J Roentgenol. 2020 Aug;215(2):338-343
pubmed: 32181672
Intensive Care Med. 2020 Jun;46(6):1099-1102
pubmed: 32291463
Minerva Anestesiol. 2012 Dec;78(12):1385-93
pubmed: 23044739
BMJ Open. 2020 Oct 10;10(10):e043651
pubmed: 33040020
Eur Respir Rev. 2020 Apr 3;29(155):
pubmed: 32248146
Am J Respir Crit Care Med. 2023 Jul 24;:
pubmed: 37487152
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Pulmonology. 2020 Jul - Aug;26(4):186-191
pubmed: 32386886
JAMA. 2020 Jul 7;324(1):57-67
pubmed: 32496521
Am J Respir Crit Care Med. 2005 Feb 1;171(3):242-8
pubmed: 15557131
Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442
pubmed: 27626833
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Crit Care. 2021 Nov 29;25(1):414
pubmed: 34844655
Intensive Care Med. 2016 May;42(5):768-771
pubmed: 27007110
Chest. 2010 Jul;138(1):114-20
pubmed: 20154071
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632

Auteurs

Martina Piluso (M)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Clarissa Ferrari (C)

Research and Clinical Trials Office, Poliambulanza Foundation Hospital, 25124 Brescia, Italy.

Silvia Pagani (S)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Pierfranco Usai (P)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Stefania Raschi (S)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Luca Parachini (L)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Elisa Oggionni (E)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Chiara Melacini (C)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Francesca D'Arcangelo (F)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Roberta Cattaneo (R)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Cristiano Bonacina (C)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Monica Bernareggi (M)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Serena Bencini (S)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Marta Nadalin (M)

School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.
Cardiothoracic Vascular Department, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Mara Borelli (M)

School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.
Cardiothoracic Vascular Department, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Roberto Bellini (R)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Maria Chiara Salandini (MC)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Paolo Scarpazza (P)

Lung Unit, Cardiothoracic Vascular Department, Vimercate Hospital, 20871 Vimercate, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH